Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talin Haritunians

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Oncology Reports|October 25, 2008
Novel acyl sulfonamide LY573636-sodium: effect on hematopoietic malignant cellsTalin Haritunians, Saskia Gueller, James O'Kelly, et al.
Seminars in Immunopathology|September 13, 2014
Use of animal models in elucidating disease pathogenesis in IBDPuja Vora Khanna, David Quan Shih, Talin Haritunians, et al.
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Cancer Science|July 17, 2008
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivoNaoki Wakimoto, Dong Yin, James O'Kelly, et al.
Iscience|October 16, 2023
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking informationRuize Liu, Dalin Li, Talin Haritunians, et al.
Leukemia Research|April 15, 2008
Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cellsTalin Haritunians, Saskia Gueller, Ling Zhang, et al.
Circulation Research|March 23, 2002
CADASIL Notch3 mutant proteins localize to the cell surface and bind ligandTalin Haritunians, Jim Boulter, Carol Hicks, et al.
World Journal of Gastroenterology|November 17, 2017
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patientsDaniel Lew, Soon Man Yoon, Xiaofei Yan, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 1, 2021
Histo-Blood Group Antigens, Enteropathogen Carriage and Environmental Enteropathy in Stunted Zambian ChildrenKanta Chandwe, Kanekwa Zyambo, Chola Mulenga, et al.
Inflammatory Bowel Diseases|May 3, 2018
Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative ColitisKristin E Burke, Hamed Khalili, John J Garber, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Oncology Reports|October 25, 2008
Novel acyl sulfonamide LY573636-sodium: effect on hematopoietic malignant cellsTalin Haritunians, Saskia Gueller, James O'Kelly, et al.
Seminars in Immunopathology|September 13, 2014
Use of animal models in elucidating disease pathogenesis in IBDPuja Vora Khanna, David Quan Shih, Talin Haritunians, et al.
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Cancer Science|July 17, 2008
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivoNaoki Wakimoto, Dong Yin, James O'Kelly, et al.
Iscience|October 16, 2023
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking informationRuize Liu, Dalin Li, Talin Haritunians, et al.
Leukemia Research|April 15, 2008
Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cellsTalin Haritunians, Saskia Gueller, Ling Zhang, et al.
Circulation Research|March 23, 2002
CADASIL Notch3 mutant proteins localize to the cell surface and bind ligandTalin Haritunians, Jim Boulter, Carol Hicks, et al.
World Journal of Gastroenterology|November 17, 2017
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patientsDaniel Lew, Soon Man Yoon, Xiaofei Yan, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 1, 2021
Histo-Blood Group Antigens, Enteropathogen Carriage and Environmental Enteropathy in Stunted Zambian ChildrenKanta Chandwe, Kanekwa Zyambo, Chola Mulenga, et al.
Inflammatory Bowel Diseases|May 3, 2018
Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative ColitisKristin E Burke, Hamed Khalili, John J Garber, et al.
Pageof 13